New SDOH data in Truveta Studio provide most complete view of health equity’s influence on patient health and outcomes
March 01, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., March 01, 2023 (GLOBE NEWSWIRE) -- Truveta announced the expansion of its de-identified data to include 28 additional social drivers of health (SDOH) attributes – such as education,...
GeneDx honors Rare Disease Day and announces presentations and research at the 2023 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
February 28, 2023 08:30 ET
|
GeneDx Holdings Corp.
STAMFORD, Conn., Feb. 28, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced its contributions to...
Truveta’s COVID-19 breakthrough infections research published in Vaccine
February 23, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 research published in Vaccine using de-identified patient data from Truveta Studio™. The new research...
Truveta’s COVID-19 breakthrough infections research published in Vaccine
February 23, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 research published in Vaccine using de-identified patient data from Truveta Studio™. The new research...
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue
February 14, 2023 09:00 ET
|
EDAP TMS S.A.
Record full-year 2022 total preliminary unaudited revenue of €55.1 million ($58.0 million) represents an increase of 25.1% over full-year 2021, driven by 58.1% HIFU growth Record Q4 2022 total...
Healthcraft Creative Solutions Named Top Data Analytics Services Company
February 08, 2023 13:33 ET
|
Healthcraft Creative Solutions
Frisco, TX, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Healthcraft Creative Solutions was one of 10 companies that were named a Top Data Analytics Services company by CIO Applications for 2022. This award...
EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis
January 31, 2023 08:00 ET
|
EDAP TMS S.A.
Focal One® HIFU treatment resulted in significant improvements in endometriosis symptoms and quality of life (QoL)Positive safety profile with 96.7% of patients with no or non-significant adverse...
Truveta expands with three new US health system members
January 24, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Three healthcare providers — HealthPartners, HonorHealth, and TriHealth — have joined Truveta, the company with a vision of saving lives with...
ClearDATA Achieves HITRUST Risk-Based, 2-Year Certification to Improve Customer Security Posture and Compliance
January 17, 2023 09:00 ET
|
ClearDATA
AUSTIN, Texas, Jan. 17, 2023 (GLOBE NEWSWIRE) -- ClearDATA®, the first comprehensive provider of healthcare-specific managed cloud, compliance and defense services, today announced their proprietary...
EDAP Announces Record Q4 US Focal One Placements
January 05, 2023 08:00 ET
|
EDAP TMS S.A.
Company preliminarily reports nine Focal One Placements in the U.S., including seven sales LYON, France, January 5, 2023 -- EDAP TMS SA (NASDAQ: EDAP) (the “Company”), the global leader in...